You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Safety and efficacy of dendritic cell vaccine for COVID-19 prevention after 1-Year follow-up: phase I and II clinical trial final result
|
|---|---|
| Published in |
Frontiers in immunology, June 2023
|
| DOI | 10.3389/fimmu.2023.1122389 |
| Pubmed ID | |
| Authors |
Jonny Jonny, Terawan Agus Putranto, Martina Lily Yana, Enda Cindylosa Sitepu, Raoulian Irfon, Bunga Pinandhita Ramadhani, Muchlis Achsan Udji Sofro, Yetty Movieta Nency, Endang Sri Lestari, Ria Triwardhani, Mujahidah, Retty Karisma Sari, Nur Alaydrus Soetojo |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Indonesia | 1 | 11% |
| Unknown | 8 | 89% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 89% |
| Science communicators (journalists, bloggers, editors) | 1 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 21 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Doctoral Student | 2 | 10% |
| Researcher | 2 | 10% |
| Lecturer | 1 | 5% |
| Other | 1 | 5% |
| Student > Ph. D. Student | 1 | 5% |
| Other | 1 | 5% |
| Unknown | 13 | 62% |
| Readers by discipline | Count | As % |
|---|---|---|
| Nursing and Health Professions | 3 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 10% |
| Neuroscience | 1 | 5% |
| Medicine and Dentistry | 1 | 5% |
| Engineering | 1 | 5% |
| Other | 0 | 0% |
| Unknown | 13 | 62% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 April 2024.
All research outputs
#5,042,943
of 26,180,352 outputs
Outputs from Frontiers in immunology
#5,629
of 32,859 outputs
Outputs of similar age
#89,719
of 387,892 outputs
Outputs of similar age from Frontiers in immunology
#141
of 1,273 outputs
Altmetric has tracked 26,180,352 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,859 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 387,892 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 1,273 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.